SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-24-013291
Filing Date
2024-03-27
Accepted
2024-03-27 16:02:36
Documents
6
Effectiveness Date
2024-03-27

Document Format Files

Seq Description Document Type Size
1 S-8 acumenpharma-sx8.htm S-8 61041
2 EX-FILING FEES exhibit107-sx8.htm EX-FILING FEES 23725
3 EX-5.1 exhibit51-sx8.htm EX-5.1 7720
4 EX-23.2 exhibit232-sx8.htm EX-23.2 2715
5 exhibit511a.jpg GRAPHIC 3169
6 logo1a.jpg GRAPHIC 39111
  Complete submission text file 0001628280-24-013291.txt   154379
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278267 | Film No.: 24790528
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)